Swift diagnosis and treatment are crucial for oncology because early detection leads to more successful, less invasive treatment options and better survival rates. Delays can allow tumors to grow, increase in stage, and potentially become metastatic, which lowers the chances of survival, increases treatment complexity, and can lead to higher costs and a worse quality of life. A rapid, integrated diagnostic process allows for faster planning and initiation of therapy, directly impacting patient outcomes and prognosis.
Importance of swift diagnosis
Improved treatment success: Diagnosing cancer early is key to a higher chance of successful treatment or even a cure.
Less invasive treatment: Early-stage cancers are often more treatable with less aggressive and invasive methods.
Better quality of life: Delaying treatment can lead to more intense therapy and associated side effects, impacting quality of life.
Importance of swift treatment
Prevents tumor progression: Time between diagnosis and treatment can allow the tumor to grow, increasing its size and stage.
Better prognosis: Multiple studies have shown that longer intervals between diagnosis and treatment are associated with lower overall survival rates.
Informs prognosis: Diagnostic tests are critical not only for treatment planning but also for informing prognosis, tracking treatment response, and assessing disease progression.
Impact of delays
Increased treatment intensity: A more advanced tumor may require more intensive therapy, which comes with increased morbidity and a higher cost.
Higher costs: Delayed diagnosis and treatment often lead to higher overall costs for care.
Reduced survival chance: The longer the delay, the lower the chance of survival.
